Scandinavian Biogas Fuels International AB (publ)
SSE:BIOGAS.ST
20.6 (SEK) • At close February 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 113.892 | 129.721 | 124.592 | 91.959 | 89.017 | 95.863 | 93.423 | 104.828 | 95.439 | 96.017 | 97.537 | 43.789 | 81.499 | 77.433 | 97.144 | 146.208 |
| Cost of Revenue
| 62.368 | 57.662 | 66.753 | 54.887 | 41.482 | 44.969 | 43.903 | 51.376 | 38.376 | 41.658 | 42.604 | 45.873 | 39.357 | 48.71 | 46.433 | 45.55 |
| Gross Profit
| 51.524 | 72.059 | 57.839 | 37.072 | 47.535 | 50.894 | 49.52 | 53.452 | 57.063 | 54.359 | 54.933 | -2.084 | 42.142 | 28.723 | 50.711 | 100.658 |
| Gross Profit Ratio
| 0.452 | 0.555 | 0.464 | 0.403 | 0.534 | 0.531 | 0.53 | 0.51 | 0.598 | 0.566 | 0.563 | -0.048 | 0.517 | 0.371 | 0.522 | 0.688 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 5.486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 21.195 | 20.81 | 17.26 | 20.971 | 21.944 | 20.194 | 19.615 | 20.024 | 18.749 | 0.152 | 13.966 | 16.52 | 15.675 | 31.62 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 55.139 | 54.374 | 21.195 | 20.81 | 17.26 | 20.971 | 21.944 | 20.194 | 19.615 | 20.024 | 18.749 | 0.152 | 13.966 | 16.52 | 15.675 | 31.62 |
| Other Expenses
| 0 | 0 | 51.982 | 41.296 | 36.893 | 47.625 | 44.441 | 34.529 | 28.92 | 32.81 | 39.547 | 33.777 | 26.594 | 32.116 | 22.351 | 53.332 |
| Operating Expenses
| 69.124 | 78.255 | 73.177 | 62.106 | 54.153 | 68.596 | 66.385 | 54.723 | 48.535 | 52.834 | 58.296 | 33.929 | 40.56 | 48.636 | 38.026 | 84.952 |
| Operating Income
| -17.6 | -6.196 | -15.338 | -20.667 | 0.155 | -17.702 | 3.47 | -1.697 | 8.528 | 1.525 | -3.363 | -16.123 | 1.582 | -19.913 | 12.685 | 15.706 |
| Operating Income Ratio
| -0.155 | -0.048 | -0.123 | -0.225 | 0.002 | -0.185 | 0.037 | -0.016 | 0.089 | 0.016 | -0.034 | -0.368 | 0.019 | -0.257 | 0.131 | 0.107 |
| Total Other Income Expenses Net
| -13.841 | -6.488 | -43.893 | -2.797 | -16.74 | -25.227 | -15.861 | 0.145 | -13.957 | -30.166 | -3.86 | 7.179 | -13.559 | -17.748 | -14.927 | -16.258 |
| Income Before Tax
| -31.441 | -12.684 | -59.231 | -23.464 | -16.585 | -42.929 | -12.391 | -4.193 | -5.429 | -28.641 | -7.223 | -28.834 | -11.977 | -37.661 | -2.242 | -0.552 |
| Income Before Tax Ratio
| -0.276 | -0.098 | -0.475 | -0.255 | -0.186 | -0.448 | -0.133 | -0.04 | -0.057 | -0.298 | -0.074 | -0.658 | -0.147 | -0.486 | -0.023 | -0.004 |
| Income Tax Expense
| -0.426 | -0.436 | -0.441 | -9.647 | -0.423 | 0.162 | -0.539 | -5.274 | -0.486 | -1.073 | 0.078 | -4.208 | -0.219 | -0.223 | -0.219 | -6.28 |
| Net Income
| -31.163 | -12.069 | -58.79 | -13.817 | -16.162 | -43.091 | -11.852 | 2.093 | -3.817 | -26.572 | -5.939 | -18.205 | -9.919 | -32.634 | -3.099 | -19.218 |
| Net Income Ratio
| -0.274 | -0.093 | -0.472 | -0.15 | -0.182 | -0.45 | -0.127 | 0.02 | -0.04 | -0.277 | -0.061 | -0.416 | -0.122 | -0.421 | -0.032 | -0.131 |
| EPS
| -0.72 | -0.28 | -1.35 | -0.32 | -0.56 | -1.47 | -0.46 | 0.04 | -0.16 | -0.9 | -0.19 | -0.61 | -0.33 | -2.55 | -0.24 | -1.5 |
| EPS Diluted
| -0.72 | -0.28 | -1.35 | -0.32 | -0.56 | -1.47 | -0.46 | 0.04 | -0.16 | -0.9 | -0.19 | -0.61 | -0.33 | -1.09 | -0.1 | -1.5 |
| EBITDA
| 12.146 | 29.323 | -20.32 | 1.486 | 20.845 | -9.267 | 23.655 | 18.707 | 30.463 | 17.88 | 22.907 | -10.618 | 21.303 | -0.269 | 30.666 | 47.205 |
| EBITDA Ratio
| 0.107 | 0.226 | -0.163 | 0.016 | 0.234 | -0.097 | 0.253 | 0.178 | 0.319 | 0.186 | 0.235 | -0.242 | 0.261 | -0.003 | 0.316 | 0.323 |